PHARMACEUTICAL DEVELOPMENT OF MEDICAL HEMOSTATIC FOAM

Abstract

This article is devoted to the pharmaceutical development of medical hemostatic foam. The method of parenchymal bleeding modeling in the liver of rats was used to assess hemostatic activity of various concentrations of aluminum and iron chloride. Also assessment of sedimentation rate and density of various samples of medical foam was made when polysorbates-20 and -80 were added to it in concentration range of 0-0,75%. It was found that from the point of view of its safety and efficacy concentration of aluminum chloride 10%, without iron salt is most acceptable. After evaluating density and sedimentation rate polysorbate-20 in concentrations of 0,25-0,75% was chosen as an additive.